On the other hand, the P2X7 receptor variant B protects cells from daunorubicin toxicity and even stimulates their proliferation, probably due to a daunorubicin-dependent ATP concentration increase in the tumor microenvironment. The gene discussed is P2RX7; the disease is neoplasm.